青年发病精神分裂症和 ADHD 的共病和非共病症状。
Shared and nonshared symptoms in youth-onset psychosis and ADHD.
机构信息
Institute of Child Development, University of Minnesota, Minneapolis, MN 55455, USA.
出版信息
J Atten Disord. 2010 Sep;14(2):121-31. doi: 10.1177/1087054709347434. Epub 2009 Oct 5.
Abstract
OBJECTIVE
We compared ratings of behavior and attention problems between youth-onset psychosis and ADHD, two disorders in which attentional impairments play a key role, and examined the effect of psychostimulant use on age of onset in psychosis.
METHOD
Parent and teacher ratings of behavioral problems and ADHD symptoms were collected using the Achenbach CBCL, TRF, and SNAP-IV Teacher Rating Scales on 42 participants with psychosis, 36 with ADHD and 57 controls (ages 8-19).
RESULTS AND CONCLUSIONS
Results suggested that academic, externalizing, and attention problems reflect symptoms shared between the disorders, whereas internalizing, social and thought problems reflect factors that differ between disorders. Furthermore, participants with psychosis who had been prescribed psychostimulants had a younger age of onset of psychotic symptoms than those who had not. This difference could reflect dissimilarities in symptom severity symptom between subgroups or potentially harmful effects of psychostimulants in individuals predisposed to develop psychosis.
摘要
目的
我们比较了青少年起病精神分裂症和 ADHD 这两种注意力损伤起关键作用的疾病之间的行为和注意力问题的评分，并研究了精神兴奋剂的使用对精神病发病年龄的影响。
方法
使用 Achenbach CBCL、TRF 和 SNAP-IV 教师评定量表，对 42 名精神分裂症患者、36 名 ADHD 患者和 57 名对照组（年龄 8-19 岁）的家长和教师进行了行为问题和 ADHD 症状的评定。
结果和结论
结果表明，学业、外化和注意力问题反映了两种疾病共有的症状，而内化、社会和思维问题则反映了两种疾病之间的差异因素。此外，服用精神兴奋剂的精神病患者的精神病症状发病年龄比未服用者小。这种差异可能反映了亚组之间症状严重程度的差异，或者精神兴奋剂在易患精神病的个体中可能产生有害影响。
相似文献
1
Shared and nonshared symptoms in youth-onset psychosis and ADHD.
J Atten Disord. 2010 Sep;14(2):121-31. doi: 10.1177/1087054709347434. Epub 2009 Oct 5.
2
High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.
J Child Adolesc Psychopharmacol. 2012 Aug;22(4):284-91. doi: 10.1089/cap.2011.0067. Epub 2012 Jul 31.
3
Parent and teacher ratings of attention-deficit/hyperactivity disorder symptoms: Factor structure and normative data.
Psychol Assess. 2016 Feb;28(2):214-25. doi: 10.1037/pas0000166. Epub 2015 May 25.
4
Evaluation of attention-deficit/hyperactivity disorder symptoms in male children with high-functioning pervasive developmental disorders.
Osaka City Med J. 2008 Jun;54(1):1-10.
5
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844.
6
Combined type versus ADHD predominantly hyperactive-impulsive type: is there a difference in functional impairment?
J Dev Behav Pediatr. 2008 Aug;29(4):270-5. doi: 10.1097/DBP.0b013e31816b6afe.
7
Clinical Subtypes in Children with Attention-Deficit Hyperactivity Disorder According to Their Child Behavior Checklist Profile.
Child Psychiatry Hum Dev. 2020 Dec;51(6):969-977. doi: 10.1007/s10578-020-00977-8.
8
How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study.
Eur Child Adolesc Psychiatry. 2008 Dec;17 Suppl 1:59-70. doi: 10.1007/s00787-008-1007-y.
9
Evaluating the utility of sluggish cognitive tempo in discriminating among DSM-IV ADHD subtypes.
J Abnorm Child Psychol. 2010 Feb;38(2):173-84. doi: 10.1007/s10802-009-9355-8.
10
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953.
引用本文的文献
1
ADHD and schizophrenia: Mere prodromal variant or homogeneous subgroup?
Schizophr Res Cogn. 2025 Jun 18;42:100374. doi: 10.1016/j.scog.2025.100374. eCollection 2025 Dec.
2
Attention-Deficit Hyperactivity Disorder and Comorbid Mental Health Conditions Associated with Increased Risk of Injury.
Psychiatry J. 2022 Oct 14;2022:2470973. doi: 10.1155/2022/2470973. eCollection 2022.
3
Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder.
Neuropsychopharmacology. 2020 Mar;45(4):649-655. doi: 10.1038/s41386-019-0555-9. Epub 2019 Oct 24.
4
Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder.
Transl Psychiatry. 2019 Oct 17;9(1):258. doi: 10.1038/s41398-019-0599-y.
5
Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia.
Acta Psychiatr Scand. 2019 Jan;139(1):89-96. doi: 10.1111/acps.12948. Epub 2018 Aug 13.
6
Symptom Overlap and Screening for Symptoms of Attention-Deficit/Hyperactivity Disorder and Psychosis Risk in Help-Seeking Psychiatric Patients.
Front Psychiatry. 2017 Oct 30;8:206. doi: 10.3389/fpsyt.2017.00206. eCollection 2017.
7
Associations of attention-deficit/hyperactivity and other childhood disorders with psychotic experiences and disorders in adolescence.
Eur Child Adolesc Psychiatry. 2017 Apr;26(4):421-431. doi: 10.1007/s00787-016-0904-8. Epub 2016 Sep 13.
8
Prescription stimulant use is associated with earlier onset of psychosis.
J Psychiatr Res. 2015 Dec;71:41-7. doi: 10.1016/j.jpsychires.2015.09.012. Epub 2015 Sep 21.
9
Raising attention to attention deficit hyperactivity disorder in schizophrenia.
World J Psychiatry. 2015 Mar 22;5(1):47-55. doi: 10.5498/wjp.v5.i1.47.
10
Detecting and treating adult attention deficit hyperactivity disorder in a patient with schizophrenia.
Neuropsychiatr. 2014;28(2):92-6. doi: 10.1007/s40211-014-0103-0. Epub 2014 May 20.
本文引用的文献
1
Incidental and intentional sequence learning in youth-onset psychosis and Attention-Deficit/Hyperactivity Disorder (ADHD).
Neuropsychology. 2009 Jul;23(4):445-59. doi: 10.1037/a0015562.
2
Divided attention in youth-onset psychosis and attention deficit/hyperactivity disorder.
J Abnorm Psychol. 2008 Nov;117(4):881-95. doi: 10.1037/a0013446.
3
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristics.
J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):979-988. doi: 10.1097/chi.0b013e31807083fd.
4
Disruption of hippocampal connectivity in children and adolescents with schizophrenia--a voxel-based diffusion tensor imaging study.
Schizophr Res. 2007 Feb;90(1-3):302-7. doi: 10.1016/j.schres.2006.09.032. Epub 2006 Dec 1.
5
High rates of comorbidity are found in childhood-onset schizophrenia.
Schizophr Res. 2006 Dec;88(1-3):90-5. doi: 10.1016/j.schres.2006.07.006. Epub 2006 Aug 17.
6
Oculomotor and manual indexes of incidental and intentional spatial sequence learning during middle childhood and adolescence.
J Exp Child Psychol. 2007 Feb;96(2):107-30. doi: 10.1016/j.jecp.2006.05.005. Epub 2006 Jul 7.
7
Improving antisaccade performance in adolescents with attention-deficit/hyperactivity disorder (ADHD).
Exp Brain Res. 2006 Sep;174(2):324-41. doi: 10.1007/s00221-006-0467-x. Epub 2006 Apr 25.
8
Premorbid indicators and risk for schizophrenia: a selective review and update.
Schizophr Res. 2005 Nov 1;79(1):45-57. doi: 10.1016/j.schres.2005.07.004.
9
Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers.
Schizophr Res. 2005 Sep 1;77(1):43-58. doi: 10.1016/j.schres.2004.12.019.
10
Attentional and neurocognitive characteristics of high-risk offspring of parents with schizophrenia compared with DSM-IV attention deficit hyperactivity disorder children.
Schizophr Res. 2005 Jul 15;76(2-3):293-9. doi: 10.1016/j.schres.2005.01.005.
Zotero 插件